CC
PLRX icon

Corton Capital’s Pliant Therapeutics PLRX Stock Holding History

Corton Capital’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,497
Closed -$138K – 355
2024
Q4 		$138K Buy
+10,497
New +$143K 0.08% 317
2024
Q3 		– Sell
-15,996
Closed -$172K – 625
2024
Q2 		$172K Buy
15,996
+4,705
+42% +$60.7K 0.09% 398
2024
Q1 		$168K Sell
11,291
-7,257
-39% -$120K 0.06% 435
2023
Q4 		$336K Buy
18,548
+7,209
+64% +$110K 0.11% 281
2023
Q3 		$197K Buy
+11,339
New +$197K 0.1% 320
2022
Q3 		– Sell
-15,747
Closed -$126K – 343
2022
Q2 		$126K Buy
+15,747
New +$101K 0.12% 271

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Corton Capital's PLRX Position: Q1 2025 in Review

Corton Capital sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 10,497 shares — an estimated $138K sold.

Corton Capital first reported a position in PLRX in Q2 2022 and held it in 6 quarters. The position peaked at $336K in Q4 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Corton Capital reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 10,497 Pliant Therapeutics shares in Q1 2025, an estimated $138K.
  • Corton Capital first reported a position in Pliant Therapeutics in Q2 2022 and held it in 6 quarters.
  • Corton Capital's Pliant Therapeutics position peaked at $336K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.